Your browser doesn't support javascript.
loading
A Novel Shigella O-Polysaccharide-IpaB Conjugate Vaccine Elicits Robust Antibody Responses and Confers Protection against Multiple Shigella Serotypes.
Desalegn, Girmay; Kapoor, Neeraj; Pill-Pepe, Lucy; Bautista, Leslie; Yin, Lu; Ndungo, Esther; Oaks, Edwin V; Fairman, Jeff; Pasetti, Marcela F.
Afiliação
  • Desalegn G; Center for Vaccine Development and Global Health (CVD), University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Kapoor N; Vaxcyte, Inc., San Carlos, California, USA.
  • Pill-Pepe L; Vaxcyte, Inc., San Carlos, California, USA.
  • Bautista L; Vaxcyte, Inc., San Carlos, California, USA.
  • Yin L; Vaxcyte, Inc., San Carlos, California, USA.
  • Ndungo E; Center for Vaccine Development and Global Health (CVD), University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Oaks EV; Patuxent Research and Consulting Group, Gambrills, Maryland, USA.
  • Fairman J; Vaxcyte, Inc., San Carlos, California, USA.
  • Pasetti MF; Center for Vaccine Development and Global Health (CVD), University of Maryland School of Medicine, Baltimore, Maryland, USA.
mSphere ; 8(3): e0001923, 2023 Jun 22.
Article em En | MEDLINE | ID: mdl-37017547
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Shigella / Vacinas contra Shigella Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Shigella / Vacinas contra Shigella Idioma: En Ano de publicação: 2023 Tipo de documento: Article